De Novo Duplication in the CHD7 Gene Associated With Severe CHARGE Syndrome

Abstract

CHARGE syndrome is an autosomal dominant developmental disorder associated with a constellation of traits involving almost every organ and sensory system, in particular congenital anomalies, including choanal atresia and malformations of the heart, inner ear, and retina. Variants in CHD7 have been shown to cause CHARGE syndrome. Here, we report the identification of a novel de novo p.Asp2119_Pro2120ins6 duplication variant in a conserved region of CHD7 in a severely affected boy presenting with 3 and 5 of the CHARGE cardinal major and minor signs, respectively, combined with congenital umbilical hernia, congenital hernia at the linea alba, mildly hypoplastic inferior vermis, slight dilatation of the lateral ventricles, prominent metopic ridge, and hypoglycemic episodes.

Keywords

Intellectual disability CHARGE syndrome WES

Introduction

CHARGE syndrome (MIM 214800) is a multifaceted condition affecting between 1 in 8500 and 1 in 17 000 individuals.¹ The acronym CHARGE was established based on the combination of patients’ phenotypes, such as coloboma, heart defect, atresia choanae (also known as choanal atresia), retardation of growth and/or development, genital defects, ear anomalies, and/or deafness in patients. All malformations related to CHARGE syndrome occur early in the first trimester of pregnancy, while growth and developmental retardation become more obvious as the child matures. In some patients, clinical phenotype overlaps with those described for other syndromes, such as DiGeorge syndrome, velocardiofacial, oculo-auriculo-vertebral, and Kallmann syndromes.^2,3 Clinical diagnosis is made with a set of criteria (Table 1) and CHARGE patients typically have all 4 major or 3 major and 3 minor features, while individuals suspected to have CHARGE syndrome may only have 1 or 2 major and several minor characteristics. Subsequent molecular confirmation enables genetic counselling concerning recurrence risk.

Table 1.

Major and minor diagnostic characteristics of CHARGE syndrome and phenotype of the proband.³

Characteristics	Manifestations	Frequency	Proband
Major diagnostic characteristics
Ocular coloboma	Coloboma of the iris, retina, choroid, disc; microphthalmia	80%–90%	• Bilateral choroid coloboma involving optic nerve
Choanal atresia or stenosis	Unilateral/bilateral: bony or membranous atresia/stenosis	50%–60%
Cranial nerve dysfunction or anomaly	I: hyposmia or anosmia	Frequent
	VII: facial palsy (unilateral or bilateral)	>40%
	VIII: hypoplasia of auditory nerve	Frequent
	IX/X: swallowing problems with aspiration	70%–90%	• Swallowing problems
Ear	Outer ear: short, wide ear with little or no lobe, ‘snipped off’ helix, prominent antihelix that is often discontinuous with tragus, triangular concha, decreased cartilage; often protruding and usually asymmetric;Middle ear: ossicular malformations;Mondini defect of the cochlea;Temporal bone abnormalities; absent or hypoplastic semicircular canals	80%–100%	• Smaller and wide right ear• Bilateral sensorineural hearing loss
Minor diagnostic characteristics
Genital hypoplasia	Males: micropenis, cryptorchidismFemales: hypoplastic labia	50%–60%	• Micropenis, cryptorchidism
Genital hypoplasia	Males and females: delayed puberty secondary to hypogonadotropic hypogonadism	Frequent
Developmental delay	Delayed milestones, hypotonia	Almost 100%	• Delayed psychomotor development• Autism spectrum disorder
Cardiovascular malformation	Including conotruncal defects (eg, tetralogy of Fallot), AV canal defects, and aortic arch anomalies	75%–85%	• Small atrial septal defect
Growth deficiency	Short stature, usually postnatal with or without growth hormone deficiency	70%–80%	• Weight and height <3rd centile
Orofacial cleft	Cleft lip and/or palate	15%–20%
Tracheoesophageal (TE) fistula	TE defects of all types	15%–20%
Distinctive facial features	Square face with broad prominent forehead, prominent nasal bridge and columella, flat midface	70%–80%	• Prominent forehead, prominent metopic ridge
Other features			• Congenital umbilical hernia and congenital hernia at the linea alba;• Mildly hypoplastic inferior vermis and slight dilatation of the lateral ventricles;• Hypoglycemic episodes

Abbreviation: AV, atreoventricular.

Methods

Whole exome sequencing

DNA was extracted from peripheral blood lymphocytes using the phenol-chloroform extraction method. The proband and his healthy parents were assessed by whole exome sequencing (WES). We followed the procedure we routinely and successfully used to identify the cause of Mendelian diseases.^4–8 Briefly, exomes were captured using the Agilent SureSelect Human All Exon V5 enrichment kit and multiplex sequenced (6-plex) on an Illumina HiSeq 2500 platform to reach about 100-fold coverage on average and were mapped according to the human reference genome build 38. Variants were filtered based on allele frequency in ExAC and in the Lithuanian population, pathogenicity predictions scores (SIFT, PolyPhen, MutationTaster, CADD),^9–13 and inheritance patterns including autosomal-recessive, X-linked, and de novo/autosomal dominant using the Varapp filtering software.¹⁴ Sanger sequencing confirmed the anticipated segregation of the potentially causative variant.

Results

The proband (3 years 7 months old; Figure 1A and B) is the firstborn male child of healthy non-consanguineous parents. Family history was unremarkable, with no undue exposure to teratogens reported. The pregnancy was complicated by imminent preterm labour at 32 weeks of gestation. The patient was born at 34 weeks of gestation with the umbilical cord wrapped around his neck and green amniotic fluid. The propositus head circumference, weight, and length at birth were 34 cm (90th centile), 2275 g (50th centile), and 49 cm (90th centile), respectively. On delivery, his Apgar scores at 1 minute and 5 minutes were 8 and 8, respectively. He was apneic at birth and was intubated for several days. He also received nasogastric tube feeding to circumvent swallowing issues. A brain magnetic resonance imaging (MRI) examination performed at 1.5 months of age showed mildly hypoplastic inferior vermis, slight dilatation of the lateral ventricles, and dilated fourth ventricle (Figure 1C and D). Brain MRI examination has not revealed anomalies of olfactory bulb, optic nerves, or pituitary gland. At 4 months of age, a gastrostomy tube was placed. Multiple congenital birth defects were observed soon after birth. An echocardiogram identified a small atrial septal defect, while a brain ultrasonographic assessment revealed inferior vermian hypoplasia. Bilateral choroid coloboma involving the optic nerves was diagnosed by an ophthalmologist at 13 months. Surgical correction was performed for a congenital umbilical hernia and a congenital hernia at the linea alba. Bilateral sensorineural hearing loss was managed with hearing aids. Hypoglycemic episodes started to manifest at approximately 9 months of age, and therapy with slow release cornstarch was initiated. Notably, there has also been clear psychomotor delay as the proband could sit without support by 15 months of age and walk independently at 37 months of age. His first teeth erupted at 14 months of age. The boy has no expressive language. At 2 years 8 months old, his psychomotor development was evaluated to be in the range of 3 (self-help) to 10 (fine motor) months according the Diagnostic Inventory for Screening Children (DISC) scale. In addition, he was diagnosed with autism spectrum disorder at 2 years 9 months of age. During his last examination, at the age of 3 years 7 months, his weight was 11.5 kg (<3rd centile) and his height was 88 cm (<3rd centile). He had a prominent metopic ridge, smaller and wide right ear, sacral dimple, clinodactyly of the 5th fingers, micropenis, and cryptorchidism. He was still suffering from laryngomalacia and severe feeding problems necessitating gastrostomy tube feeding. Frequent feeds and uncooked cornstarch every 6 hours was used to prevent hypoglycemic episodes. In summary, the proband presents with 3 major and 5 minor features of CHARGE syndrome (Table 1) combined with additional features.

Figure 1.

(A) Front and (B) side views of the patient at 1 year and 9 months of age. Brain MRI at 1.5 months of age showed (C) slight dilatation of the lateral ventricles, mildly hypoplastic inferior vermis and (D) dilated fourth ventricle. (E) An electropherogram of the genomic DNA sequence of the patient showed a de novo duplication in CHD7: c.6341_6358dup (Asp2119_Pro2120ins6) A mutated sequence with duplication in red written beneath. (F) Alignment of CHD7 protein fragment for 9 different placental mammal species confirmed that the Asp2119_Pro2120ins6 non-frameshift insertion affects an evolutionary conserved region. Secondary structures of the peptide encoded by the wild type (left) and Asp2119_Pro2120ins6 mutated (right) exon 31 of CHD7 are shown as rainbow ribbons. (G) The new short alpha helix that is formed by the inserted amino acid residues is in yellow. Models of wild-type and mutated protein structure were formed using SWISS-MODEL software.¹⁵ MRI indicates magnetic resonance imaging.

As no cytogenetic alterations were identified, we assessed the genome of the proband and his parents by WES. We identified a de novo 18 nucleotides duplication in exon 31 of the CHD7 gene (c.6341_6358dup, p.Asp2119_Pro2120ins6); NM_017780; NP_060250; MIM 214800) confirmed by Sanger sequencing (Figure 1E), which affects an evolutionary constrained region (Figure 1F). Modelization of the putatively encoded mutated protein suggests that the insertion of this chain of 6 amino acid residues potentially substitutes a linear chain into a short alpha helix (Figure 1G). The other deleterious de novo variants, which contribute to the current patient phenotype, were not identified. All unique de novo variants identified for this proband are listed in Table 2.

Table 2.

List of de novo variants identified for the proband.

Chromosome	Start	Reference allele	Alternative allele	Gene symbol	Aa change	Impact	Genotype
chr20	52557934	GGT	G	AC005220.3		Splice donor variant	Heterozygous
chr7	150811966	G	A	AGAP3	G/S	Missense variant	Heterozygous
chr7	150811967	G	A	AGAP3	G/D	Missense variant	Heterozygous
chr11	13435092	T	G	BTBD10	K/Q	Missense variant	Heterozygous
chr11	66512290	G	GGGCGGCGGCGGC	C11orf80	G/GAAAA	Inframe insertion	Heterozygous
chr2	153476066	G	GCCACCCCCCCCCCCA	FMNL2	−/PPPPP	Inframe insertion	Heterozygous
chr6	30996720	C	CAGGCTCTGAGACCACCACAGCCTCTACTGA	MUC22	T/TGSETTTASTE	Inframe insertion	Heterozygous
chr19	2015540	GGGCGGCGGCGGC	G	BTBD2	AAAA/−	Inframe deletion	Homozygous
chr3	42251577	C	CGGA	TRAK1	T/TE	Inframe insertion	Heterozygous
chr14	73874252	G	–	PTGR2		NA	Heterozygous
chr4	87615711	AATAGTAGTGACAGCAGC	–	DSPP		Non-frameshift deletion	Heterozygous
chr8	60853065	–	ATCACATCCTCAATGACC	CHD7	−/HILNDH	Non-frameshift insertion	Heterozygous

De novo variant in CHD7 gene associated with CHARGE syndrome is marked in grey.

Discussion

Alterations in CHD7 have been identified in more than two-third of all children, who fulfil the clinical diagnostic criteria for CHARGE syndrome.^16–18 Truncating variants including nonsense, frameshift, and splice variants (89%) that typically result in haploinsufficiency are the most frequently encountered followed by missense (8%) variants.^17,19,20 CHD7 encodes a chromodomain helicase DNA-binding protein, which plays a significant role in early embryonic development and controls gene expression via chromatin remodelling during the cell cycle.²¹

Besides the duplication described here, other variants affecting the same region in the protein have been identified, for example, the de novo missense variant c.6347T>A; p.Ile2116Asn (CM090041) that changes a hydrophobic into a polar amino acid. The associated patient presented with a milder pheno-type than our proband characterized by cleft palate, auricular dysplasia, nystagmus, bilateral perceptive deafness, and semi-circular canal hypoplasia.²² Similarly, the c.6322G>A; p.Gly2108Arg (CM080142) missense variant has been detected in 3 patients with mild CHARGE syndrome features, which include unilateral optic nerve coloboma and microphthalmia, bilateral sensorineural deafness, dysmorphic ears, hypoplastic semicircular canals, and bifid uvula.²³ The association between the insertion of the HILNDH peptide and a severe phenotype is not surprising as it is predicted to form a novel alpha helix within a highly conserved region of the protein.

While additional work is necessary to understand this complex disease, this study further expands the understanding of CHARGE syndrome pathogenesis and suggests that severe CHARGE syndrome phenotypes can be caused by deletions, point mutations,¹⁷ and duplications/insertions.

Footnotes

Acknowledgements

We extend our sincere appreciation to the patient’s family for their support.

Funding:

The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This study was supported by the Lithuanian-Swiss Cooperation Programme under UNIGENE project agreement no. CH-3-ŠMM-01/04 and a grant from the Swiss National Science Foundation (31003A_160203) to AR.

Declaration of conflicting interests:

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Author Contributions

LP performed data analysis. LP and EP prepared the manuscript. Sequencing of trios exomes was performed by LG. AR and VK contributed to conception and design and critically revised the manuscript.

Ethical Approval

The patient’s parents provided written informed consent to publish all clinical information, including photographs of the patient.

References

Issekutz

Graham

Jr Prasad

Smith

Blake

KD.

An epidemiological analysis of CHARGE syndrome: preliminary results from a Canadian study. Am J Med Genet A. 2005;133A:309–317.

Blake

MacCuspie

Hartshorne

Roy

Davenport

Corsten

Postoperative airway events of individuals with CHARGE syndrome. Int J Pediatr Otorhinolaryngol. 2009;73:219–226.

Vuorela

Penttinen

Hietala

Laine

Huoponen

Kääriäinen

HA.

A familial CHARGE syndrome with a CHD7 nonsense mutation and new clinical features. Clin Dysmorphol. 2008;17:249–253.

Borck

Hög

Dentici

et al . BRF1 mutations alter RNA polymerase III-dependent transcription and cause neurodevelopmental anomalies. Genome Res. 2015;25:155–166.

Alfaiz

Micale

Mandriani

et al . TBC1D7 mutations are associated with intellectual disability, macrocrania, patellar dislocation, and celiac disease. Hum Mutat. 2014;35:447–451.

Lodder

De Nittis

Koopman

et al . GNB5 mutations cause an autosomal-recessive multisystem syndrome with sinus bradycardia and cognitive disability. Am J Hum Genet. 2016;99:704–710.

Tumienė

Voisin

Preikšaitienė

et al . Inflammatory myopathy in a patient with Aicardi-Goutières syndrome. Eur J Med Genet. 2017;60:154–158.

Gueneau

Fish

Shamseddin

et al . KIAA1109 variants are associated with a severe disorder of brain development and arthrogryposis. Am J Hum Genet. 2018;102:116–132.

Petrovski

Wang

Heinzen

Allen

Goldstein

DB.

Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet. 2013;9:e1003709.

10.

Schwarz

Rödelsperger

Schuelke

Seelow

MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7:575–576.

11.

Henikoff

Predicting deleterious amino acid substitutions. Genome Res. 2001;11:863–874.

12.

Adzhubei

Schmidt

Peshkin

et al . A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–249.

13.

Lek

Karczewski

Minikel

et al . Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–291.

14.

Delafontaine

Masselot

Liechti

Kuznetsov

Xenarios

Pradervand

. Varapp: a reactive web-application for variants filtering [published online ahead of print June 28, 2016]. bioRxiv. doi:https://doi.org/10.1101/060806.

15.

Biasini

Bienert

Waterhouse

et al . SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014;42:W252–W258.

16.

Bergman

Janssen

Hoefsloot

Jongmans

Hofstra

van Ravenswaaij-Arts

CM.

CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype. J Med Genet. 2011;48:334–342.

17.

Katoh-Fukui

Yatsuga

Shima

et al . An unclassified variant of CHD7 activates a cryptic splice site in a patient with CHARGE syndrome. Hum Genome Var. 2018;5:18006.

18.

Martin

DM.

Epigenetic developmental disorders: CHARGE syndrome, a case study. Curr Genet Med Rep. 2015;3:1–7.

19.

Vissers

van Ravenswaaij

Admiraal

et al . Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet. 2004;36:955–957.

20.

Zentner

Layman

Martin

Scacheri

PC.

Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A. 2010;152A:674–686.

21.

Sanlaville

Etchevers

Gonzales

et al . Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J Med Genet. 2006;43:211–217.

22.

Jongmans

van Ravenswaaij-Arts

Pitteloud

et al . CHD7 mutations in patients initially diagnosed with Kallmann syndrome – the clinical overlap with CHARGE syndrome. Clin Genet. 2009;75:65–71.

23.

Jongmans

Hoefsloot

van der Donk

et al . Familial CHARGE syndrome and the CHD7 gene: a recurrent missense mutation, intrafamilial recurrence and variability. Am J Med Genet A. 2008;146A:43–50.